Detailed Information on Publication Record
2024
Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
MORAVCOVA, Katarina, Marketa SOVOVA, Jaromir OZANA, Martina KARBANOVÁ, Jan KLASEK et. al.Basic information
Original name
Comparing the Efficacy of Digital and In-Person Weight Loss Interventions for Patients with Obesity and Glycemic Disorders: Evidence from a Randomized Non-Inferiority Trial
Authors
MORAVCOVA, Katarina (203 Czech Republic), Marketa SOVOVA (203 Czech Republic), Jaromir OZANA (203 Czech Republic), Martina KARBANOVÁ (203 Czech Republic, belonging to the institution), Jan KLASEK (203 Czech Republic), Agnieszka Barbara KOLASINSKA (203 Czech Republic) and Eliska SOVOVA (203 Czech Republic)
Edition
Nutrients, Basel, MDPI, 2024, 2072-6643
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
30304 Public and environmental health
Country of publisher
Switzerland
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 5.900 in 2022
Organization unit
Faculty of Medicine
UT WoS
001231311000001
Keywords in English
obesity; digital therapeutics; lifestyle intervention; diabetes mellitus type 2; insulin resistance
Tags
Tags
International impact, Reviewed
Změněno: 10/6/2024 08:33, Mgr. Tereza Miškechová
Abstract
V originále
Digital weight loss interventions present a viable and cost-effective alternative to traditional therapy. However, further evidence is needed to establish the equal effectiveness of both approaches. This randomized controlled non-inferiority trial aimed to compare the effects of an intensive in-person weight loss intervention program with Vitadio digital therapy. One hundred patients with obesity and diagnosed with type 2 diabetes, prediabetes, or insulin resistance were enrolled and randomly assigned to one of the two treatment groups. Over a 6-month period, the control group received five in-person consultations with a physician who specialized in obesity treatment, a dietitian and/or a nutrition nurse, while the intervention group followed the digital program based on a multimodal therapeutic approach. The extent of weight loss was assessed and compared between the groups. Additionally, changes in body composition and metabolic parameters for the digital intervention group were analyzed. The study results demonstrated comparable effectiveness of both treatments for weight reduction. The positive effects of Vitadio were further evidenced by favorable changes in body composition and lipid metabolism and improved glycemic control in the intervention group. These findings suggest that Vitadio is an effective tool for assisting patients with managing obesity and preventing diabetes progression.